Author： Walenga Jeanine M Jeske Walter P Frapaise F Xavier Bick Rodger L Fareed Jawed Samama M Michel
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.11, Iss.3, 2002-03, pp. : 397-407
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Cilostazol as a Unique Antithrombotic Agent
Current Pharmaceutical Design, Vol. 9, Iss. 28, 2003-11 ,pp. :
Fondaparinux sodium/heparin: Heparin-induced thrombocytopenia in an elderly patient: case report
Reactions Weekly, Vol. 1, Iss. 1431, 2012-01 ,pp. :
Enoxaparin/eptifibatide vs heparin/eptifibatide: antithrombotic effects
Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. :
Current Pharmaceutical Design, Vol. 11, Iss. 4, 2005-02 ,pp. :